LIMR’s Dr. Prendergast chairs programs at AACR workshop

By Donna Loyle, communications specialist, LIMR

George Prendergast, PhD, president and CEO of the Lankenau Institute for Medical Research (LIMR), was a member of the organizing faculty for the American Association for Cancer Research workshop, “Translational Cancer Research for Basic Sciences,” held October 22-27 in Boston. Dr.  Prendergast served as chair of the panel discussion “Entrepreneurship in Translational Research,” which featured leaders of four companies that have participated in LIMR’s biotech incubator, including Immunome, RiboNova, Leading Edge Ventures, and NewLink Genetics. Dr. Prendergast also served as chair of the workshop’s special seminar and group discussion, “Unleashing the Power of Immune System: Focus on Translational Immunology.”

This entry was posted in Clinician News and tagged . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *